Aditxt Correlations
ADTX Stock | USD 0.37 0.02 5.71% |
The current 90-days correlation between Aditxt Inc and Dermata Therapeutics is 0.19 (i.e., Average diversification). The correlation of Aditxt is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Aditxt Correlation With Market
Significant diversification
The correlation between Aditxt Inc and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aditxt Inc and DJI in the same portfolio, assuming nothing else is changed.
Aditxt |
Moving together with Aditxt Stock
0.67 | ELAN | Elanco Animal Health | PairCorr |
0.69 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.65 | RDY | Dr Reddys Laboratories | PairCorr |
0.73 | TAK | Takeda Pharmaceutical | PairCorr |
0.62 | LTRN | Lantern Pharma | PairCorr |
0.62 | ANRO | Alto Neuroscience, | PairCorr |
0.79 | SIGA | SIGA Technologies | PairCorr |
Moving against Aditxt Stock
0.92 | EWTX | Edgewise Therapeutics | PairCorr |
0.85 | BHC | Bausch Health Companies | PairCorr |
0.79 | GILD | Gilead Sciences | PairCorr |
0.78 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.76 | GANX | Gain Therapeutics | PairCorr |
0.67 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.62 | EBS | Emergent Biosolutions | PairCorr |
0.55 | WAT | Waters | PairCorr |
0.52 | HCM | HUTCHMED DRC | PairCorr |
0.52 | BCTXW | BriaCell Therapeutics | PairCorr |
0.32 | VTRS | Viatris | PairCorr |
0.76 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
0.57 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.39 | CMND | Clearmind Medicine Common | PairCorr |
0.37 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
0.35 | MNMD | Mind Medicine | PairCorr |
0.33 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aditxt Stock performing well and Aditxt Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aditxt's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NRBO | 3.35 | (0.50) | 0.00 | (2.54) | 0.00 | 6.76 | 25.62 | |||
DRMA | 4.92 | (0.61) | 0.00 | (0.22) | 0.00 | 9.22 | 69.06 | |||
UNCY | 4.14 | 1.07 | 0.19 | 0.84 | 4.13 | 10.26 | 29.22 | |||
REVB | 3.64 | (0.67) | 0.00 | (0.22) | 0.00 | 8.97 | 34.52 | |||
PALI | 3.46 | (0.36) | 0.00 | 0.61 | 0.00 | 5.97 | 24.25 | |||
PSTV | 3.89 | (0.02) | 0.00 | (0.18) | 0.00 | 7.63 | 41.21 | |||
QNRX | 5.95 | 0.39 | 0.06 | 0.40 | 6.53 | 17.65 | 74.46 | |||
ALLR | 4.97 | (2.02) | 0.00 | (1.87) | 0.00 | 10.85 | 41.48 | |||
KRBP | 6.00 | (0.40) | 0.00 | (0.10) | 0.00 | 12.04 | 65.24 | |||
VRAX | 5.71 | (0.95) | 0.00 | 2.22 | 0.00 | 9.65 | 61.28 |
Aditxt Corporate Management
CPA CPA | President | Profile | |
Thomas CPA | Chief Officer | Profile | |
Matthew Shatzkes | Chief Counsel | Profile | |
MS MD | Senior Discovery | Profile | |
Dr D | Senior Transplantation | Profile | |
Amro Albanna | Chairman CoFounder | Profile |